Work

Benign course of SARS‐CoV‐2 infection in a series of pediatric oncology patients

Year: 2020
Type: article
Abstract: Jenna Rossoff, Ami B. Patel, and Emily Muscat declare that there is no conflict of interest or competing financial interest. Larry K. Kociolek received grant funding from Merck. William J. Muller is consulting for Seqirus, Inc. and received research funding for clinical trials from Abbott Laboratories, Ansun BioPharma, Astellas Pharma, AstraZeneca, Janssen Pharmaceutica, Karius, Melinta, Merck, Roche, and Tetraphase.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3036980540
FWCI: 0.819
Cites: 10
Cited by: 27
Related to: 10